Litcius/Paper detail

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

Olivia S. Costa, Jan Beyer‐Westendorf, Veronica Ashton, Dejan Milentijevic, Kenneth Todd Moore, Thomas J. Bunz, Craig I Coleman

2020Journal of Thrombosis and Thrombolysis34 citationsDOI

Topics & Concepts

MedicineRivaroxabanWarfarinHazard ratioInternal medicineBody mass indexCohortVenous thromboembolismProportional hazards modelEmergency departmentConfidence intervalThrombosisAtrial fibrillationPsychiatryVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesBlood Pressure and Hypertension Studies
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data | Litcius